CSL Limited CSL Limited

CSL Limited

CSL

Xếp hạng trong cổ phiếu #363
CSL Limited operates as a global biopharmaceutical company, engaged in the... CSL Limited operates as a global biopharmaceutical company, engaged in the research, development, manufacturing, marketing, and distribution of diverse pharmaceutical and allied products. Its extensive international footprint includes key markets such as Australia, the United States, Germany, the United Kingdom, Switzerland, and China. The company is structured into two principal operating segments: CSL Behring and CSL Seqirus. CSL Behring focuses on plasma-derived therapies, encompassing both plasma products and recombinant treatments. This segment also conducts significant research into both plasma and non-plasma therapeutics and derives revenue from intellectual property licensing and royalties. In contrast, CSL Seqirus is dedicated to the manufacturing and worldwide distribution of non-plasma biotherapeutic products, alongside developing a range of influenza-related solutions. Founded in 1916, CSL Limited maintains its corporate headquarters in Parkville, Australia.
Giá cổ phiếu
$137.83
Vốn hóa thị trường
$66.14B
Thay đổi (1 ngày)
0.87%
Thay đổi (1 năm)
-3.78%
Quốc gia
AU
Giao dịch CSL Limited (CSL)

Danh mục

Healthcare
Lịch sử giá cổ phiếu của CSL Limited (CSL)
Giá đóng cửa cao nhất: $130.93 vào 2026-10-01

Giá đóng cửa thấp nhất: $0.58 vào 1994-05-01
Lịch sử giá cổ phiếu của CSL Limited từ 1994 đến 2026
Hiệu suất giá cổ phiếu hàng năm
Năm Hiệu suất
2026 (TTM) -11.03%
2025 -33.22%
2024 -3.40%
2023 -7.34%
2022 -5.55%
2021 -4.35%
2020 13.64%
2019 48.92%
2018 19.64%
2017 51.86%
2016 -2.99%
2015 3.42%
2014 17.66%
2013 7.48%
2012 72.89%
2011 -9.64%
2010 27.38%
2009 31.88%
2008 -30.73%
2007 91.54%
2006 59.34%
2005 39.55%
2004 69.88%
2003 10.97%
2002 -54.53%
2001 23.69%
2000 47.80%
1999 54.18%
1998 35.94%
1997 57.11%
1996 56.41%
1995 57.26%
1994 0.00%
Giá cổ phiếu của các công ty hoặc đối thủ tương tự
Công ty Giá cổ phiếu Thay đổi 1năm% Quốc gia
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $530.66 24.44%
US
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $230.18 757.28%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $890.66 9.40%
NL
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $290.41 2.03%
BE
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $764.04 8.59%
CH